Latest AI and machine learning research in other cancers for healthcare professionals.
PURPOSE: Accurate identification of the primary tumor diagnosis of patients who have undergone stereotactic radiosurgery (SRS) from electronic health records is a critical but challenging task. Traditional methods of identifying the primary tumor histology relying on International Classification of Diseases (ICD)9 and ICD10 CM codes often fall short in granularity and completeness, particularly fo...
INTRODUCTION: Melanoma is a highly aggressive skin cancer that accounts for a disproportionate number of skin cancer-related deaths due to early metastasis and therapy resistance. Programmed cell death (PCD), including ferroptosis and apoptosis, plays a crucial role in tumor progression and therapy response. Among these, triaptosis is a newly described form of PCD. It represents a novel mechanism ...
PURPOSE: This study aimed to evaluate radiomic models' ability to predict hypoxia-related biomarker expression in clear cell renal cell carcinoma (ccR...
PURPOSE: Uterine sarcoma is a rare disease whose association with body composition parameters is poorly understood. This study explored the impact of ...
The evaluation of bone marrow pathology is essential for diagnosing and classifying myeloproliferative neoplasms (MPNs). However, morphological assess...
BACKGROUND AND OBJECTIVES: Endoprosthetic reconstruction is the preferred approach for limb salvage surgery for many patients following malignant bone...
BACKGROUND: Nasopharyngeal carcinoma (NPC) lacks biomarkers demonstrating both high specificity and sensitivity for early diagnosis. This study aimed ...
Background and study aims Prophylactic total gastrectomy (PTG) is the definitive treatment for hereditary diffuse gastric cancer syndrome (HDGC). Endo...
This investigation examined the factors involved in predicting the responses of micrometastases to targeted Ac-based therapies and in optimizing these...
Hepatocellular carcinoma (HCC) is a malignant tumor with high incidence and mortality rates globally, significantly affecting patient prognosis and qu...
BackgroundPatients in palliative care often experience prolonged hospital stays, requiring detailed documentation, complex symptom management, and mul...
Extrachromosomal circular DNA (eccDNA) may contribute to genomic rearrangements and tumor heterogeneity, playing a role in cancer development and prog...
Targeted combined immunotherapy (TCI) has shown certain antitumor effects in patients with unresectable hepatocellular carcinoma(uHCC), but only a su...
As a highly prevalent tumor in males, prostate cancer (PCa) needs newly developed biomarkers to guide prognosis and treatment. However, few researche...
INTRODUCTION: Lung neuroendocrine carcinomas (Lu-NECs) are rare, highly aggressive lung tumors with poor prognosis and limited therapeutic options. Un...
Gastric cancer is one of the most common malignant tumors of the digestive system, with a high mortality rate due to late-stage diagnosis. Current cli...
BACKGROUND: Next-generation sequencing (NGS) has become a cornerstone of treatment for lung cancer and is recommended in current treatment guidelines ...
PURPOSE: The choice of wound closure modality after limb-sparing extremity soft-tissue sarcoma (eSTS) resection is fraught with uncertainty. Leveragin...
PURPOSE: With increasing use of human epithelial growth factor receptor two (HER2)-targeted therapies, outcomes for numerous breast cancer patients ha...
Early identification and referral of inflammatory breast cancer (IBC) remains challenging within large healthcare systems, limiting access to speciali...